Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus
Vancomycin has been used as the last resort in the clinical treatment of serious Staphylococcus aureus infections. Vancomycin-intermediate S. aureus (VISA) was discovered almost two decades ago. Aside from the vancomycin-intermediate phenotype, VISA strains from the clinic or laboratory exhibited co...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2016-10-01
|
| Schriftenreihe: | Frontiers in Microbiology |
| Schlagworte: | |
| Online-Zugang: | http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.01601/full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|